{"transactions":[{"id":4616422,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:28:07.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13405,"derivative":{"underlying":"Common Stock","underlying_shares":590},"source":{"system":"sec-edgar","filing":"0002110603-26-000013","document":"wk-form4_1789165685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2110603/000211060326000013/wk-form4_1789165685.xml","form_type":"4"}},{"id":4616421,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:07.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":285,"price":144.81,"value":41270.85,"ownership":{"direct":true},"balance_after":8759,"source":{"system":"sec-edgar","filing":"0002110603-26-000013","document":"wk-form4_1789165685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2110603/000211060326000013/wk-form4_1789165685.xml","form_type":"4"}},{"id":4616420,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:07.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":590,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":9044,"source":{"system":"sec-edgar","filing":"0002110603-26-000013","document":"wk-form4_1789165685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2110603/000211060326000013/wk-form4_1789165685.xml","form_type":"4"}},{"id":306379,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T20:51:01.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":6002,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three-year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three-year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":13995,"derivative":{"underlying":"Common Stock","underlying_shares":6002},"source":{"system":"sec-edgar","filing":"0002110603-26-000010","document":"wk-form4_1786481458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000010/wk-form4_1786481458.xml","form_type":"4"}},{"id":306378,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-08-11T20:51:01.000Z","date":"2026-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2908,"price":133.06,"value":386938.48,"ownership":{"direct":true},"balance_after":8454,"source":{"system":"sec-edgar","filing":"0002110603-26-000010","document":"wk-form4_1786481458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000010/wk-form4_1786481458.xml","form_type":"4"}},{"id":306377,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-08-11T20:51:01.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":6002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":11362,"source":{"system":"sec-edgar","filing":"0002110603-26-000010","document":"wk-form4_1786481458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000010/wk-form4_1786481458.xml","form_type":"4"}},{"id":308341,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:34:06.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":589,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":19997,"derivative":{"underlying":"Common Stock","underlying_shares":589},"source":{"system":"sec-edgar","filing":"0002110603-26-000008","document":"wk-form4_1781217244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000008/wk-form4_1781217244.xml","form_type":"4"}},{"id":308340,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-06-11T22:34:06.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":283,"price":121.48,"value":34378.84,"ownership":{"direct":true},"balance_after":5360,"source":{"system":"sec-edgar","filing":"0002110603-26-000008","document":"wk-form4_1781217244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000008/wk-form4_1781217244.xml","form_type":"4"}},{"id":308339,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-06-11T22:34:06.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":5643,"source":{"system":"sec-edgar","filing":"0002110603-26-000008","document":"wk-form4_1781217244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000008/wk-form4_1781217244.xml","form_type":"4"}},{"id":311601,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-03-12T20:39:59.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":18885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":18885,"derivative":{"exercise_price":148.56,"expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":18885},"source":{"system":"sec-edgar","filing":"0002110603-26-000006","document":"wk-form4_1773347997.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000006/wk-form4_1773347997.xml","form_type":"4"}},{"id":311600,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:39:59.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":5050,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":20586,"derivative":{"underlying":"Common Stock","underlying_shares":5050},"source":{"system":"sec-edgar","filing":"0002110603-26-000006","document":"wk-form4_1773347997.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000006/wk-form4_1773347997.xml","form_type":"4"}},{"id":311599,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:39:59.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1246,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":15536,"derivative":{"underlying":"Common Stock","underlying_shares":1246},"source":{"system":"sec-edgar","filing":"0002110603-26-000006","document":"wk-form4_1773347997.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000006/wk-form4_1773347997.xml","form_type":"4"}},{"id":311598,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-03-12T20:39:59.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":606,"price":148.56,"value":90027.36,"ownership":{"direct":true},"balance_after":5054,"source":{"system":"sec-edgar","filing":"0002110603-26-000006","document":"wk-form4_1773347997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000006/wk-form4_1773347997.xml","form_type":"4"}},{"id":311597,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-03-12T20:39:59.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1246,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":5660,"source":{"system":"sec-edgar","filing":"0002110603-26-000006","document":"wk-form4_1773347997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000006/wk-form4_1773347997.xml","form_type":"4"}},{"id":312357,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-03-02T21:48:33.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":4414,"source":{"system":"sec-edgar","filing":"0002110603-26-000004","document":"wk-form4_1772488110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000004/wk-form4_1772488110.xml","form_type":"4"}}]}